Zobrazeno 1 - 10
of 62
pro vyhledávání: '"ROBERT C. WALLACH"'
Autor:
Esther Yoon, Leslie R. Boyd, Ilan E. Timor-Tritsch, Caroline Brandon, Robert C. Wallach, Ana Monteagudo, Jeanine Ciaffarano, K. Mittal
Publikováno v:
Journal of Ultrasound in Medicine. 38:2973-2978
Objectives Cystadenofibromas (CAFs) are rare benign ovarian tumors without a widely accepted ultrasound (US) pattern. They are usually described by as thin-walled, unilocular or multilocular, and at times septated cysts with scant blood flow and no s
Autor:
Robert C. Wallach
Publikováno v:
Obstetrics and gynecologyREFERENCE. 127(3)
Autor:
Eleni Andreopoulou, John P. Curtin, Stephanie V. Blank, Thomas C. Chen, Howard S. Hochster, Robert C. Wallach, Leonard Liebes, Franco M. Muggia
Publikováno v:
Cancer Chemotherapy and Pharmacology. 68:457-463
Most ovarian cancers recur after first-line treatment. We studied the pharmacology, tolerability, and therapeutic potential of intraperitoneal (IP) topotecan, alone and with IP cisplatin.Patients received IP topotecan 1.5 mg (flat dose) daily on days
Autor:
K. Mittal, Robert C. Wallach, Caroline Brandon, J. Giaffarano, A. Monteagudo, Alan A. Arslan, Ilan E. Timor-Tritsch, Leslie R. Boyd, Esther Yoon
Publikováno v:
Ultrasound in Obstetrics & Gynecology. 52:8-8
Autor:
Joan Cangiarella, Robert C. Wallach, Paul Elgert, Aylin Simsir, Risha B. Ramdall, Pascale Levine, Guoping Cai
Publikováno v:
Acta Cytologica. 53:1-9
Objective To quantify the frequency and significance of glandular cells in posthysterectomy liquid-based (SurePath, TriPath Imaging, Burlington, North Carolina, U.S.A.) vaginal Pap tests. Study Design The presence of benign glandular cells in vaginal
Autor:
John Mandeli, Franco M. Muggia, Robert C. Wallach, John J. Wright, James Speyer, Joan Sorich, Elizabeth R. Plimack, Howard S. Hochster, Scott Wadler, Carolyn D. Runowicz
Publikováno v:
Journal of Clinical Oncology. 22:120-126
Purpose To determine the antitumor activity of the novel topoisomerase I inhibitor 9-aminocamptothecin (9-AC) given over 72 hours every 2 weeks in patients with ovarian carcinoma previously treated with one platinum-containing regimen. Patients and M
Publikováno v:
Pediatric annals. 4(7)
Autor:
Scott Wadler, Gary L. Goldberg, H. Haynes, Abbie Fields, Robert E. Gallagher, Robert C. Wallach, Steven J. Hallam, Ronalde Rameau, Carolyn D. Runowicz, Scott Jennings, John Mandeli, Astrid Quish, Edward L. Schwartz, Frances McGill
Publikováno v:
Cancer. 79:1574-1580
BACKGROUND Recent clinical trials with a combination of interferon (IFN alpha) and 13 cis-retinoic acid resulted in high response rates among women with locally advanced and metastatic carcinoma of the uterine cervix. The authors sought to amplify th
Autor:
Susan Edwards, Franco M. Muggia, Robert C. Wallach, Maryann Kwa, Elsa Reich, Andrea Downey, John P. Curtin
Publikováno v:
Annals of surgical oncology. 21(5)
Ovarian cancer arising in women with BRCA mutations is known to have a more favorable outcome and to be more responsive to platinum-based regimens than in those without a hereditary background. We analyze our previously published intraperitoneal (IP)
Publikováno v:
Gynecologic and Obstetric Investigation. 49:70-72
We report a case of xanthogranulomatous tubo-ovarian abscess which was preoperatively suspected to be an adnexal neoplasm. With foreign body material found in the abscess wall and vegetable fiber in the tubal lumen, a previously treated chronic diver